Semaglutide and alcohol intolerance — anyone have experience?

CarlaRPh_TPA said:

Steady state is the thing most people miss.

Thank you — that is the clearest version of this I have read, and I have read a lot of them.

From the other side of the consultation, briefly.

Dr.SurgeonPGH said:

...but the FDA says semaglutide...

Interesting point. I want to add some regulatory nuance: the FDA labeling reflects the specific clinical trial data submitted for approval. Real-world clinical practice often extends beyond the FDA label based on emerging evidence and clinical judgment.

Example: semaglutide was first approved for diabetes (Ozempic), then obesity (Wegovy). The molecule didn't change — our understanding of its applications expanded. Similarly, semaglutide may evolve as more data accumulates.

andrew_nyc said:

The mechanism that matters here is not stomach emptying, it is central.

I read this differently from andrew_nyc, on substance rather than tone. The trial means are being read too generously in this thread. STEP populations were selected, supported, and titrated by protocol, and the real-world curves are consistently a few points worse. That difference is not noise, it is what happens when you remove the study infrastructure.

One concrete data point for the thread. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here.